Insight Molecular Diagnostics (IMDX) Amortizatization of Intangibles (2015 - 2025)
Insight Molecular Diagnostics' (IMDX) quarterly Amortizatization of Intangibles came in at $7000.0 in Q1 2025, down 68.18% year-on-year from $22000.0 in Q1 2024, and down 68.18% quarter-over-quarter from $22000.0 in Q4 2024.
Insight Molecular Diagnostics (IMDX) Amortizatization of Intangibles (2015 - 2025) Analysis & Trends
Insight Molecular Diagnostics has disclosed Amortizatization of Intangibles across 10 years of filings, most recently posting $7000.0 for Q1 2025.
- Amortizatization of Intangibles for Q1 2025 came in at $7000.0, down 68.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $7000.0 (down 92.05% YoY), and the FY2025 annual result was $7000.0, down 92.05% from the prior year.
- Amortizatization of Intangibles came in at $7000.0 for Q1 2025 at Insight Molecular Diagnostics, down from $22000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.1 million in Q2 2021 to a low of $7000.0 in Q1 2025.
- The 5-year median for Amortizatization of Intangibles is $22000.0 (2023), against an average of $425647.1.
- Across the five-year window, Amortizatization of Intangibles soared 4781.82% in 2021 and sank 97.75% in 2023, its largest moves.
- Insight Molecular Diagnostics' Amortizatization of Intangibles stood at $990000.0 in 2021, then dropped by 17.98% to $812000.0 in 2022, then slumped by 97.29% to $22000.0 in 2023, then changed by 0.0% to $22000.0 in 2024, then slumped by 68.18% to $7000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $7000.0 (Q1 2025), $22000.0 (Q4 2024), and $22000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 171.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 430.00 Mn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 434.00 Mn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | - |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 7.10 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 18.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | - |
| 10 | Insight Molecular Diagnostics | 4.44 Mn | -24.49 Mn | 15,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | 22,000.00 |
| Sep 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 812,000.00 |
| Dec 31, 2022 | 812,000.00 |